Safety, Survival, and Efficacy of Preserving Left Colonic Artery in Rectal Cancer Surgery: A Meta-analysis and Review

Journal of Laparoendoscopic&Advanced Surgical Techniques, Ahead of Print.
Source: Journal of Laparoendoscopic - Category: Surgery Authors: Source Type: research

Related Links:

Publication date: Available online 21 September 2019Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Author(s): Qiuping Fan, Dongqiong Huang, Minggang Su
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research
ConclusionCapOX therapy is feasible as adjuvant chemotherapy for locally advanced rectal cancer.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
Conclusions: Transanal total mesorectal excision offers a safe and feasible alternative to LaTME although the clinicopathological features were not superior to LaTME in this study. Currently, with the lack of evidence on benefits of TaTME, further evaluation of TaTME requires large randomized control trials to be conducted. PMID: 31534564 [PubMed]
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Tags: Wideochir Inne Tech Maloinwazyjne Source Type: research
Journal of Laparoendoscopic&Advanced Surgical Techniques, Ahead of Print.
Source: Journal of Laparoendoscopic and Advanced Surgical Techniques - Category: Surgery Authors: Source Type: research
Conditions:   Rectal Neoplasms;   Rectal Cancer Intervention:   Radiation: Preoperative Radio(Chemo)Therapy Sponsors:   Maria Sklodowska-Curie Institute - Oncology Center;   Polish Society of Surgical Oncology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Rectal Cancer Intervention:   Sponsor:   Mahidol University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cancer of Rectum Interventions:   Radiation: 50.4 Gy to the tumor and elective volume;   Radiation: 62 Gy to the clinical tumor volume and 50.4 Gy to the elective volume;   Drug: Capecitabine 825 mg/m2 twice daily on weekdays Sponsor:   Vejle Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Rectal Neoplasms;   Rectal Cancer Intervention:   Radiation: Preoperative Radio(Chemo)Therapy Sponsors:   Maria Sklodowska-Curie Institute - Oncology Center;   Polish Society of Surgical Oncology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Rectal Cancer Intervention:   Sponsor:   Mahidol University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cancer of Rectum Interventions:   Radiation: 50.4 Gy to the tumor and elective volume;   Radiation: 62 Gy to the clinical tumor volume and 50.4 Gy to the elective volume;   Drug: Capecitabine 825 mg/m2 twice daily on weekdays Sponsor:   Vejle Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Rectal Cancers | Surgery